X
  • No products in the list

SLCO1B1 PCR Assay

Short description

The SLCO1B1 c.521T>C RealFast™ Assay is a PCR test that detects a genetic variant responsible for simvastatin-induced myopathy, a severe side effect of statin treatment. Simvastatin is a widely prescribed statin for reducing LDL cholesterol levels, but its adverse events, including myopathy and rhabdomyolysis, are concerning.

The c.521T>C variant of the SLCO1B1 gene affects the hepatic uptake and metabolism of statins, leading to increased risk of simvastatin-induced myopathy in patients carrying the c.521C allele. The assay identifies the c.521T>C genotype in a human DNA extract, enabling personalized dose adjustment of simvastatin according to CPIC guidelines. Personalized dosing guided by genetic testing improves patient safety and reduces the risk of statin-induced myopathy associated with empirical dosing.

Product highlights

  • Personalized medicine
  • Reducing the risk of potentially dangerous side effects
  • Fast and accurate detection of the SLCO1B1 c.521T>C variant
  • Can be performed in a standard laboratory setting
  • Cost-effective solution for determining SLCO1B1 genotype

Ask for a quote

SLCO1B1 PCR Assay

More
information

Downloads

Instructions for Use

Brochure

MSDS

 

Specifications of the SLCO1B1 PCR Assay

Introducing the SLCO1B1 c.521T>C RealFast™ Assay – the fast and accurate PCR test for detecting a genetic variant responsible for simvastatin-induced myopathy, a severe side effect of statin treatment.

Simvastatin is a widely prescribed statin for reducing LDL cholesterol levels, but its dose-dependent adverse events, including myopathy and rhabdomyolysis, are concerning. The c.521T>C variant of the SLCO1B1 gene affects the hepatic uptake and metabolism of statins, leading to increased risk of simvastatin-induced myopathy in patients carrying the c.521C allele.

The SLCO1B1 c.521T>C RealFast™ Assay identifies the c.521T>C genotype in a human DNA extract, enabling personalized dose adjustment of simvastatin according to CPIC guidelines. By avoiding the risk of simvastatin-induced myopathy, patients can benefit from the lipid-lowering effects of statin therapy without experiencing severe side effects.

Trust in Viennalab’s expertise and experience in molecular diagnostics to provide you with reliable and easy-to-use results for your laboratory workflow. Improve patient safety and reduce the risk of statin-induced myopathy associated with empirical dosing – add the SLCO1B1 c.521T>C RealFast™ Assay to your laboratory today.

Components of the SLCO1B1 PCR Assay
  1. DNA Extraction Kit: A kit containing all the reagents necessary for the extraction of genomic DNA from a blood or saliva sample, including DNA extraction buffer, proteinase K, and magnetic beads.
  2. PCR Mix: A ready-to-use mix containing all the reagents necessary for the PCR amplification of the SLCO1B1 gene region of interest.
  3. SLCO1B1 Primer Mix: A mix of primers specific for the SLCO1B1 gene region of interest.
  4. Probe Mix: A mix of probes specific for the detection of SNPs in the SLCO1B1 gene.
  5. Control DNA: A synthetic DNA that is added to the sample as an internal control to ensure that the assay is working correctly.
  6. DNase/RNase-free Water: Water that has been treated to remove contaminating DNases and RNases, which can degrade the extracted DNA.

 

The kit also includes instructions for use, as well as a protocol for the detection of SNPs in the SLCO1B1 gene using real-time PCR.

Explore Related Items